Related Experiment Videos
Endogenous digoxin-immunoreactive substance in normal and preeclamptic pregnancies
G Loğoğlu1, S Erdoğan, F T Ozgünen
1Department of Physiology, Cukurova University Medical Faculty, Adana, Turkey.
Summary
This study found that endogenous digoxin-immunoreactive substance levels in pregnant women do not predict preeclampsia. These levels showed no significant correlation with gestational age or blood pressure in preeclamptic pregnancies.
Area of Science:
- Reproductive Medicine
- Cardiovascular Physiology
- Biochemistry
Background:
- Preeclampsia is a serious pregnancy complication characterized by hypertension.
- Endogenous digoxin-like substances have been investigated for their potential role in cardiovascular regulation during pregnancy.
Purpose of the Study:
- To assess the predictive value of serum digoxin-immunoreactive substance for preeclampsia.
- To examine the relationship between these substance levels, gestational age, and blood pressure in preeclamptic pregnancies.
Main Methods:
- Serum digoxin-immunoreactive substance concentrations were measured using radioimmunoassay (RIA).
- Comparisons were made between normotensive and preeclamptic pregnant women in their third trimesters.
- Statistical analyses included the Mann-Whitney U-test and correlation-regression analysis.
Main Results:
- Mean serum digoxin-immunoreactive substance levels were similar in normotensive (0.29 ng/ml) and preeclamptic (0.31 ng/ml) groups, with no statistical significance.
- No significant correlation was observed between substance levels and gestational age or systolic blood pressure in preeclamptic patients.
Conclusions:
- An endogenous digoxin-immunoreactive substance is present in late pregnancy sera.
- This substance does not appear to play a role in the pathogenesis or prediction of preeclampsia.